js105
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Jan 11, 2024 (NCT06208410)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07207070 | Phase 3 | Nov 28, 2025 | Innovaderm, Risen (Suzhou) Pharma Tech Co., Ltd. |
| NCT06208410 | Phase 1/Phase 2 (Phase 2) | Jan 11, 2024 | Risen (Suzhou) Pharma Tech Co., Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Risen (Suzhou) Pharma Tech Co., Ltd. | For profit | 2 | 2 | 2 | 2024 |
| Innovaderm | For profit | 1 | 0 | 1 | 2025 |
2 organizations
Page 1 / 1